8.2.4: Other immunomodulating drugs

Part of chapter 8 Malignant Disease and Immunosuppression, section 8.2 Drugs affecting the immune response

High-level prescribing trends for Other immunomodulating drugs (BNF section 8.2.4) across NHS North East London for the last five years. You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site.

View all matching dm+d items.

No prescriptions found.

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.

Chemicals

Aldesleukin (0802041A0)
Bacillus calmette-guerin (B.C.G.) (0802040X0)
Belimumab (0802040AF)
Cladribine (Immunomodulating) (0802040AY)
Dabrafenib (old) (0802040AI)
Dimethyl fumar (0802040AK)
Fingolimod (0802040AD)
Glatiramer acetate (0802040U0)
Interferon alpha (0802040J0)
Interferon beta (0802040M0)
Interferon gamma (0802040Z0)
Lenalidomide (0802040Y0)
Natalizumab (0802040W0)
Peginterferon alpha (0802040A0)
Peginterferon beta (0802040AP)
Pomalidomide (0802040AJ)
Siponimod (0802040BB)
Teriflunomide (0802040AL)
Thalidomide (Immunomodulating) (0802040AA)
Tivozanib (old) (0802040BA)
Feedback